:: BioVeris to Fund Up to $600,000 for
Chlamydia Vaccine Development ::
September 2005: Two Microbiology faculty members, Elizabeth Stuart, Associate Professor of Microbiology, and Wilmore Webley, Assistant Professor of Microbiology, are currently part of a research team geared at developing a vaccine for Chlamydia, the most frequently reported sexually transmitted disease in the United States. BioVeris Corporation has pledged up to $600,000 to UMass to assist in the development of the vaccine. UMass and BioVeris have entered into an agreement giving the compamy exclusive patent rights to the chlamydia vaccine. Read more... |
